Press Releases
Lilly’s TRAILBLAZER-ALZ 2 Trial is Partnering with the Global Alzheimer’s Platform Foundation® to Shatter the Slow Completion Timeframes of Alzheimer’s Clinical Trials
TRAILBLAZER-ALZ 2 is the second study of donanemab, which showed favorable results in an earlier trial. Washington, DC (March 13, 2021) – Eli Lilly and Company, a leader in Alzheimer’s research for over 30 years, is partnering with the Global Alzheimer’s Platform Foundation® (GAP) to accelerate recruitment services and expand the number of clinical research […]
STATEMENT: ELI LILLY’S PHASE 2 DONANEMAB STUDY RESULT IS CAUSE FOR CELEBRATION
Statement by GAP President John Dwyer on the results of the Phase 2 trial for Donanemab: We congratulate Eli Lilly on the results of the Donanemab clinical trial showing it significantly slowed the cognitive and functional decline of people with mild Alzheimer’s. This is a major step towards discovery of a disease modifying therapy. Alzheimer’s […]
STATEMENT: BIOGEN AND APPLE PARTNERSHIP SPEEDS SEARCH FOR ALZHEIMER’S TEST; SHOULD PRIORITIZE DIVERSITY
Statement by Global Alzheimer’s Platform Foundation (GAP) President John Dwyer on today’s announcement that Biogen and Apple are partnering on an observational study to investigate the role Apple Watch and iPhone could play in screening for mild cognitive impairment (MCI): Today’s announcement by Biogen and Apple marks a significant step on the path to early […]
Investment in Diversity and Rapid, Early Diagnostics Is Essential to the Search for a Cure for Alzheimer’s Disease
Global Alzheimer’s Platform Foundation® Chief Science Officer Dr. Richard Mohs testifies at Senate hearing about the Alzheimer’s crisis. Watch the full hearing at United States Senate Committee on Finance. Washington, DC (December 16, 2020) – Today, the Chief Science Officer of the Global Alzheimer’s Platform Foundation® (GAP), Dr. Richard Mohs, testified before the Senate Committee on Finance, […]
STATEMENT: NEW DATA PLATFORM WILL EXPEDITE INNOVATION AND DRIVE COLLABORATION FOR ALZHEIMER’S DISEASE RESEARCH
Washington, DC (November 25, 2020) – The President of the Global Alzheimer’s Platform Foundation (GAP), John Dwyer, issued the following statement regarding the Alzheimer’s Disease Data Initiative’s (ADDI) launch of the new Alzheimer’s disease data platform, AD Workbench. “Congratulations on the launch of AD Workbench, by our colleagues at the Alzheimer’s Disease Data Initiative (ADDI). The publicly […]
Global Alzheimer’s Platform Foundation® President Testifies before FDA Advisory Committee in Support of Breakthrough Alzheimer’s Drug
GAP President John Dwyer says aducanumab offers disease-modifying benefit significantly exceeding current therapies Contact: Pamela Larkin, 408-466-5952, [email protected] Washington, DC (November 6, 2020) – Today, the President of the Global Alzheimer’s Platform Foundation® (GAP), John Dwyer, testified before the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee regarding Biogen’s breakthrough Alzheimer’s drug aducanumab. Given that clinical […]
STATEMENT: BLOOD TEST FOR ALZHEIMER’S IS A MAJOR ADVANCEMENT FOR PATIENTS, RESEARCHERS & PHYSICIANS
Contact: Pamela Larkin, 408-466-5952, [email protected] Washington, DC (October 29, 2020) – The President of the Global Alzheimer’s Platform Foundation (GAP), John Dwyer, issued the following statement regarding C2N Diagnostics’ release of the PrecivityADTM blood test. “Congratulations to the C2N Diagnostics team for successfully developing the first blood test of its kind for Alzheimer’s disease. It will transform […]
West Palm Beach State Representative Receives National Award for Alzheimer’s Volunteerism
The Global Alzheimer’s Platform Foundation® Recognizes Rep. Matt Willhite (D-86) with the 2020 National Citizen Scientist Collaborator Award® Contact: Pamela Larkin – [email protected], 408-466-5952 Contact: Belinda Russel – [email protected], 561-968-2933 West Palm Beach, FL (October 22, 2020) – The Global Alzheimer’s Platform Foundation® (GAP) has recognized State Representative Matt Willhite (D-86) as the honoree of […]
Pawleys Island Resident with Alzheimer’s Receives National Award for Alzheimer’s Volunteerism
The Global Alzheimer’s Platform Foundation® Recognizes Deborah Whelan with the 2020 National Citizen Scientist Champion Award® Contact: Pamela Larkin – [email protected], 408-466-5952 Contact: Robert Briggs – [email protected], 267-879-1762 Charleston, SC (October 22, 2020) – The Global Alzheimer’s Platform Foundation® (GAP) has recognized Deborah Whelan, a retiree living with Alzheimer’s disease, as the recipient of the National Citizen Scientist Champion Award®. […]
Westford Retiree Receives National Award for Alzheimer’s Volunteerism
The Global Alzheimer’s Platform Foundation® Has Recognized Dennis Chan for the 2020 National Citizen Scientist Catalyst Award® Contact: Pamela Larkin – [email protected], 408-466-5952 Boston, MA (October 22, 2020) – The Global Alzheimer’s Platform Foundation® (GAP) has recognized Westford retiree Dennis Chan as the honoree of the National Citizen Scientist Catalyst Award®. The Center for Alzheimer […]